Wednesday evening during the Mad Money program Jim Cramer mentioned Johnson & Johnson (JNJ) as a company that was less risky than some of the vaccine makers that have gotten frothy lately. Let's check out their charts.
More from Investing
How the battle of value vs. growth stocks is resolved, we will have to wait and see.
JWN is not a retail name that looks constructive.
Here's our latest analysis and trading strategy for this retail name.
This one doesn't have options, so it would be a pure stock play now.